Gastroenterology

Switch From Biosimilar to Originator Infliximab Safe in IBD




(MedPage Today) — No significant changes in clinical remission, trough levels, or antidrug antibody status

Source link




Related posts

High- vs Low-Intensity CRC Surveillance?

Newsemia

Postpartum New-Onset Mental Illness Risk Up With IBD

Newsemia

Survivor Care; Diabetes and Cancer; Lung Cancer Ignorance

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy